Used in conjunction with the actuator
Designed for pulmonary, upper respiratory tract, and nasal cavity
Effective dose: 50, 63, 75, 100, 120, 150 μL.
Customizable to formulation.
Accurate spray dosage.
Valve core diameter Φ: 2.80mm
Suitable for HFA solution and suspension formulations
Minimal residue
All polymer materials meet the strictest pharmaceutical requirements
Suitable for one-step/two-step, cold pouring process requirements
Our engineering team has the expertise to support you in every stage of product development lifecycle. We are capable of identifying new ways to optimize supply chains, minimizing compliance risks, reducing manufacturing waste, and providing the highest quality standards with on-time delivery and maintain commercially acceptable cost of goods.
In addition, our experienced innovation team is committed to pioneering new technologies that enable us to develop reliable and robust products to meet and exceed your expectations.
